Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome in HCC – Mechanisms, diagnosis and therapy
Robert F. Schwabe, Tim F. Greten
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 230-238
Open Access | Times Cited: 275

Showing 1-25 of 275 citing articles:

Immunotherapies for hepatocellular carcinoma
Josep M. Llovet, Florian Castet, Mathias Heikenwälder, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 3, pp. 151-172
Closed Access | Times Cited: 1170
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Romain Donné, Amaia Lujambio
Hepatology (2022) Vol. 77, Iss. 5, pp. 1773-1796
Closed Access | Times Cited: 327
Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies
Frederik Soetaert, Preethi Korangath, David Serantes, et al.
Advanced Drug Delivery Reviews (2020) Vol. 163-164, pp. 65-83
Open Access | Times Cited: 322
Gut microbiome, liver immunology, and liver diseases
Rui Wang, Ruqi Tang, Bo Li, et al.
Cellular and Molecular Immunology (2020) Vol. 18, Iss. 1, pp. 4-17
Open Access | Times Cited: 303
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 290
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Daniel Q. Huang, Philippe Mathurin, Helena Cortez‐Pinto, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 1, pp. 37-49
Open Access | Times Cited: 277
Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
Jinzhu Mao, Dongxu Wang, Junyu Long, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 12, pp. e003334-e003334
Open Access | Times Cited: 188
Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma
Qianfei Zhang, Chi Ma, Yi Duan, et al.
Cancer Discovery (2020) Vol. 11, Iss. 5, pp. 1248-1267
Open Access | Times Cited: 176
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment
Kai Markus Schneider, Antje Mohs, Wenfang Gui, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 135
Gut microbiota influence tumor development and Alter interactions with the human immune system
Yanshan Ge, Xinhui Wang, Yali Guo, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 115
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Kuei‐Chuan Lee, Pei-Shan Wu, Han‐Chieh Lin
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. 1, pp. 77-98
Open Access | Times Cited: 113
d -lactate modulates M2 tumor-associated macrophages and remodels immunosuppressive tumor microenvironment for hepatocellular carcinoma
Shulan Han, Xueying Bao, Yifang Zou, et al.
Science Advances (2023) Vol. 9, Iss. 29
Open Access | Times Cited: 110
Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention
Naomi F. Lange, Pompilia Radu, Jean‐François Dufour
Journal of Hepatology (2021) Vol. 75, Iss. 5, pp. 1217-1227
Open Access | Times Cited: 105
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 104
Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 97
Interactive Relationships between Intestinal Flora and Bile Acids
Xiaohua Guo, Edozie Samuel Okpara, Wanting Hu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8343-8343
Open Access | Times Cited: 95
Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression
Lirong Peng, Banglun Pan, Xiaoxia Zhang, et al.
Cell Biology and Toxicology (2022) Vol. 38, Iss. 6, pp. 1159-1173
Closed Access | Times Cited: 84
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Mengwei Zhang, Jinkai Liu, Qiang Xia
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 50
Role of the microbiota in response to and recovery from cancer therapy
Stephen J. Blake, Yochai Wolf, Ben Boursi, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 308-325
Closed Access | Times Cited: 46
Molecular mechanisms in MASLD/MASH-related HCC
Xiaobo Wang, Liang Zhang, Bingning Dong
Hepatology (2024)
Closed Access | Times Cited: 43
Metabolic reprogramming in the tumor microenvironment of liver cancer
Jian Lin, Dongning Rao, Mao Zhang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 41
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 38
Enhanced capacity of a leaf beetle to combat dual stress from entomopathogens and herbicides mediated by associated microbiota
Yuxin ZHANG, Handan XU, Chengjie Tu, et al.
Integrative Zoology (2024) Vol. 19, Iss. 6, pp. 1092-1104
Closed Access | Times Cited: 25
Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma
Amanda Garrido, Nabil Djouder
Trends in cancer (2020) Vol. 7, Iss. 1, pp. 29-36
Closed Access | Times Cited: 101
Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
Ruipeng Zheng, Guoqiang Wang, Zhiqiang Pang, et al.
Cancer Medicine (2020) Vol. 9, Iss. 12, pp. 4232-4250
Open Access | Times Cited: 93
Page 1 - Next Page

Scroll to top